Efficacy and safety of intravitreal Fluocinolone Acetonide microimplant (ILUVIEN ®) in patients with chronic diabetic macular edema: 1 year follow-up.

MLA

Pacella, Fernanda, et al. “Efficacy and Safety of Intravitreal Fluocinolone Acetonide Microimplant (ILUVIEN ®) in Patients with Chronic Diabetic Macular Edema: 1 Year Follow-Up.” European Journal of Ophthalmology, vol. 32, no. 2, Mar. 2022, pp. 1109–13. EBSCOhost, https://doi.org/10.1177/11206721211020203.

APA

Pacella, F., Pacella, E., Trovato Battagliola, E., Malvasi, M., Scalinci, S. Z., Turchetti, P., Salducci, M., Lucchino, L., & Arrico, L. (2022). Efficacy and safety of intravitreal Fluocinolone Acetonide microimplant (ILUVIEN ®) in patients with chronic diabetic macular edema: 1 year follow-up. European Journal of Ophthalmology, 32(2), 1109–1113. https://doi.org/10.1177/11206721211020203

Chicago

Pacella, Fernanda, Elena Pacella, Edoardo Trovato Battagliola, Mariaelena Malvasi, Sergio Zaccaria Scalinci, Paolo Turchetti, Mauro Salducci, Luca Lucchino, and Loredana Arrico. 2022. “Efficacy and Safety of Intravitreal Fluocinolone Acetonide Microimplant (ILUVIEN ®) in Patients with Chronic Diabetic Macular Edema: 1 Year Follow-Up.” European Journal of Ophthalmology 32 (2): 1109–13. doi:10.1177/11206721211020203.